Episode

Lenacapavir offering new hope for HIV prevention?

Podcast
Focus on Africa
Published
Jun 25, 2026
Duration seconds
1379
Processing state
not_requested
Canonical source
http://www.bbc.co.uk/programmes/p0nv2qfm
Audio
http://open.live.bbc.co.uk/mediaselector/6/redir/version/2.0/mediaset/audio-nondrm-download-rss/proto/http/vpid/p0nv2mk0.mp3
JSON
/v1/public/podcasts/focus-on-africa-160336/episodes/lenacapavir-offering-new-hope-for-hiv-prevention
Markdown
/podcast/focus-on-africa-160336/lenacapavir-offering-new-hope-for-hiv-prevention.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/focus-on-africa-160336/episodes/lenacapavir-offering-new-hope-for-hiv-prevention/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/focus-on-africa-160336/lenacapavir-offering-new-hope-for-hiv-prevention.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

The United Nations has warned that nearly three million children could contract HIV by 2040, with more than half at risk of dying from AIDS-related illnesses if prevention and treatment efforts are not significantly expanded. The agency says the overwhelming majority of these infections are expected to occur in sub-Saharan Africa, where young people remain disproportionately affected by the epidemic. Amid these concerns, a major scientific breakthrough is offering new hope. Lenacapavir, a long-acting HIV prevention injection administered just twice a year, is being hailed as a potential game-changer, particularly for young people and others who struggle to adhere to daily prevention pills. In United States, Minnesota , the fentanyl epidemic continues to devastate families and communities, with overdose deaths leaving a lasting toll. Presenter: Nkechi Ogbonna Producers: Blessing Aderogba Technical Producer: Herbert Masua Senior Producer: Keikantse Shumba Editors: Charles Gitonga and Maryam Abdalla